Support 'My Patient's Choice' pledge

A carer’s pledge to offer patients an informed choice between a novel drug or an injectable drug for the treatment of MDR-TB.

Read More →

TB HLM Community Consultation launched

The Affected Communities and Civil Society Advisory Panel to the UN High-Level Meeting on TB (TB HLM) launches the first phase of the TB HLM Community Consultation.

Read More →

Call for new membership: Communities Delegation to Unitaid Board

The Communities Delegation to the Unitaid Board represents people living with and affected by HIV, TB and malaria and those co-infected with HIV and HCV, at the Unitaid Board and Committee level.

Read More →

WHO call for patient data on the treatment of drug-resistant TB

Public call for individual patient data on treatment of multidrug- and rifampicin-resistant TB.

Read More →

New guide: Your rights and TB care

An innovative and important new TB resource – Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide.

Read More →

Advocates call on WHO to consolidate and revise its guidance regarding the treatment for MDR-TB

TB CAB issues a position statement on the use of bedaquiline as part of the preferred regimen for MDR-TB.

Read More →

Resolution on upcoming UN High-Level Meeting on TB

WHO Executive Board adopts resolution on upcoming United Nations General Assembly High-Level Meeting on TB.

Read More →

WHO leadership meets with TB civil society

WHO leadership meets with TB civil society to strengthen engagement in accelerating the End TB response.

Read More →

TB Europe Coalition releases two new publications

A brochure about the forthcoming United Nations High-Level Meeting on TB and a set of infographics.

Read More →

WHO position statement on the use of delamanid for MDR-TB

The World Health Organization issues a position statement on the use of delamanid for multidrug-resistant TB following an expedited review of phase III clinical trial results.

Read More →

Page 1 of 86 · Total posts: 10

1 2 Last→